Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound formulation for myopia, hypermetropia, strabismus and amblyopia

A compound preparation and hyperopia technology, which is applied to the compound western medicine preparation of amblyopia and nystagmus to treat myopia, strabismus and hyperopia, and can solve the problems of short-term curative effect and easy recurrence

Inactive Publication Date: 2004-06-02
张淑清
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] In the prior art, there are many kinds of physical therapy and drugs for treating eye diseases such as myopia and amblyopia, but the curative effect is short-lived and easy to relapse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Embodiment 1: the compound preparation for the treatment of eye diseases such as myopia, hyperopia, strabismus and amblyopia comprises following composition (weight is gram):

[0019] Zinc Sulfate 10 B Vitamins 1 25 Vitamin B2 5

[0020] Vitamin B 6 10 Niacin 15

[0021] The following ingredients are mixed and processed into fine powder, and filled into 0.25g capsules.

[0022] The functions of the above ingredients are as follows: Zinc is the most important nutrient substance of the retina and choroid, which can maintain the growth and development of visual cells. Juvenile myopia, hyperopia, and amblyopia are congenital dysplasia diseases, and it is combined with vitamin B 6 , B 2 , B 1 And niacin to activate visual cells, promote blood circulation, make visual cells have sufficient oxygen supply, and accelerate cell metabolism and regeneration.

Embodiment 2

[0023] Embodiment 2: also add following composition (weight is gram) in the capsule as described in embodiment 2:

[0024] Vitamin B 12 500 Vitamin A 1 Vitamin D 1 Calcium Gluconate 0.5 Calcium Phosphate 0.5 Calcium Lactate 0.5

[0025] The pharmacological effects of the above ingredients are: to improve myopia, congenital dysplasia, lack of nutrition, poor elasticity of eyeball sclera, insufficient toughness and other calcium deficiency manifestations, adding vitamin A to nourish retinal rod cells, improve peripheral vision and night blindness symptoms.

Embodiment 3

[0026] Embodiment 3: can also add following composition (weight is gram) in the capsule as described in embodiment 2:

[0027] Adenosine triphosphate 4 Inosine 200 Folic acid 15

[0028] The pharmacological effects of the above ingredients are to promote the metabolism of retinal visual cells with low energy and hypoxic cells, enhance the reactivity of visual cells, enhance the neuroregulatory effect, improve vision, and enhance physical fitness.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The compound preparation for treating eye diseases is prepared with zinc sulfate, nicotinic acid, vitamins and other ingredients and through mixing, grinding and capsulizing. The compound preparation has obvious and stable curative effect owing to its functions of promoting nerve cell regeneration, strengthening regulation of No. 3 nerve and raising eyesight.

Description

technical field [0001] The invention relates to a compound preparation for treating eye diseases, in particular to a compound western medicine preparation for treating myopia, hyperopia, strabismus, amblyopia and nystagmus. Background technique [0002] In the prior art, there are many kinds of physical therapy and medicine for the treatment of eye diseases such as myopia and amblyopia, but the curative effect is short-lived and easy to relapse. And the focus of treatment is not to activate the optic cells, promote blood circulation, and qualitatively change the function of the optic nerve cells. Contents of the invention [0003] The purpose of the present invention is to overcome above-mentioned deficiency, provide a kind of fundamental treatment method of treating eye diseases such as myopia, amblyopia, treating both symptoms and root causes, remarkable curative effect, long-term curative effect consolidation. [0004] The obje...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K33/30A61P27/02
Inventor 张淑清
Owner 张淑清
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com